Pharmacotherapy and Psychotherapy in the Treatment of Erectile Dysfunction
Not Applicable
Completed
- Conditions
- Erectile Dysfunction
- Interventions
- Behavioral: Cognitive Behavioral PsychotherapyCombination Product: Combined or Integrated TherapyOther: Placebo
- Registration Number
- NCT04126252
- Lead Sponsor
- International Islamic University, Islamabad
- Brief Summary
The study involved the administration of pharmacotherapy and cognitive behavior psychotherapy to individuals suffering from erectile dysfunction. The study was randomized controlled trial with four arms involving a control group.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Male
- Target Recruitment
- 116
Inclusion Criteria
- Men diagnosed with erectile dysfunction
- Must be in the age range of 18 to 40 years
- Must be in a stable heterosexual relationship
- Must not be suffering from any medical or psychiatric illness
Exclusion Criteria
- Men not meeting criteria of diagnosis of erectile dysfunction
- Men not in a heterosexual relationship
- Men above the age of 40 years
- Men diagnosed with any medical or psychiatric illness
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SEQUENTIAL
- Arm && Interventions
Group Intervention Description Group A Sildenafil Citrate 50Mg Tab This arm received pharmacotherapy for erectile dysfunction. Group B Cognitive Behavioral Psychotherapy This arm received cognitive behavior psychotherapy for erectile dysfunction. Group C Combined or Integrated Therapy This arm received combined treatment approach. Group D Placebo This arm acted as a control group and received placebo or no intervention.
- Primary Outcome Measures
Name Time Method International Index of Erectile Functioning-5 3 months maximum
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie sildenafil citrate's efficacy in erectile dysfunction?
How does cognitive behavioral therapy compare to PDE5 inhibitors in treating psychogenic ED?
Are there specific biomarkers that predict response to combined pharmacotherapy and psychotherapy for ED?
What are the long-term adverse event profiles of sildenafil citrate versus placebo in ED trials?
How does integrated therapy compare to standard monotherapies in treating vasculogenic erectile dysfunction?
Trial Locations
- Locations (1)
Ahmad Bilal Private Practice
🇵🇰Bahāwalpur, Punjab, Pakistan
Ahmad Bilal Private Practice🇵🇰Bahāwalpur, Punjab, Pakistan